SCM
BLFS icon

Soleus Capital Management’s BioLife Solutions BLFS Stock Holding History

Soleus Capital Management’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-439,000
Closed -$6.06M – 81
2023
Q3 		$6.06M Buy
+439,000
New +$6.92M 0.56% 47

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Soleus Capital Management's BLFS Position: Q4 2023 in Review

Soleus Capital Management sold out of BioLife Solutions (BLFS) in Q4 2023, closing a stake of 439,000 shares — an estimated $6.06M sold.

Soleus Capital Management first reported a position in BLFS in Q3 2023 and held it in 1 quarter. The position peaked at $6.06M in Q3 2023. 140 funds tracked by Wall St. Rank hold BLFS as of Q4 2023.

  • Soleus Capital Management reported no remaining BioLife Solutions position as of Q4 2023 after selling out during the quarter.
  • Soleus Capital Management sold 439,000 BioLife Solutions shares in Q4 2023, an estimated $6.06M.
  • Soleus Capital Management first reported a position in BioLife Solutions in Q3 2023 and held it in 1 quarter.
  • Soleus Capital Management's BioLife Solutions position peaked at $6.06M in Q3 2023.
  • 140 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2023.

Based on Soleus Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.